SCHEDULE 13G

Company

Mirum Pharmaceuticals, Inc.

Filed

December 16, 2019

Accession Number

0001172661-19-002410

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →